Loading…
← CockpitCompetitor Analysis › 301188.SZ Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class AOpen in the cockpit ↗

Shandong Linuo Pharmaceutical Packaging Co., Ltd. Class A301188.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Home Furnishings

Chinese maker of pharmaceutical rubber-stopper and packaging materials, part of the Linuo industrial group.

Momentum laggard 3
Mkt cap
$814M
US dollars, full cap
Free float
37%
of shares outstanding
$/day
$26.5M
20-day average traded
Fwd P/E
64.4×
forward earnings
ROIC−WACC
-7.6 pp
WACC 12.7%
Hurdle
n/a
no reverse DCF
Next earnings
162 days
29 Apr 2027
Close · CNYCN¥20.75
1D0.0%
1W-15.0%
1M-24.2%
3M-51.2%
6M-41.5%
YTD+17.9%
1Y+21.9%
ATR %8.1%
52w lowhigh72.8% off high

What Shandong Linuo Pharmaceutical Packaging does

Chinese maker of pharmaceutical rubber-stopper and packaging materials, part of the Linuo industrial group.

Products and services

  • Pharmaceutical rubber stoppers

Customers

  • Pharmaceutical/injectable-drug manufacturers

Where it sits in the supply chain

  • Materials
  • Pharma packaging
  • Rubber stoppers/closures

What could go right

  • Injectable-drug packaging demand

What could go wrong

  • Customer concentration
  • Regulatory compliance costs

Moat: narrow (customer qualification, regulatory licence). Pharma packaging requires drug-regulatory qualification, creating switching costs.

Headquarters: Jinan, Shandong, China · Employees: 1,403

Named competitors

Shandong Linuo Pharmaceutical Packaging at a glance

Size Shandong Linuo Pharmaceutical Packaging (301188.SZ) is a China Materials company (Home Furnishings) with a market value of $814M, the 2554th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥20.75 on 18 Nov 2026.

Performance Over six months the shares fell 41.5%, against -30.6% for the median peer and -20.0% for the China market (cap-weighted) — 4th lowest of 20 in its peer set.

Growth Revenue grew 30.1% over the last twelve months (peer median +11.1%); the operating margin is 2.9% (peer median 5.8%).

Valuation It trades at 64.4× forward earnings against a peer median of 17.4× (most expensive of 10).

Capital Return on invested capital runs 7.6 points below its cost of capital (12.7% WACC).

Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).

Relative performance

5010015021 May 202621 Aug 202618 Nov 2026Peer median 71301188.SZ 53
Six months, rebased to 100: Shandong Linuo Pharmaceutical Packaging against the median of its 20 peers (local-currency closes).

Shandong Linuo Pharmaceutical Packaging financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.26BCN¥979MCN¥1.08BCN¥945MCN¥820M
Revenue growth—-9%+14%+15%—
Gross profitCN¥378MCN¥197MCN¥198MCN¥156MCN¥174M
EBITDAn/aCN¥175MCN¥181MCN¥143MCN¥164M
Net incomeCN¥30.0MCN¥39.7MCN¥66.1MCN¥65.9MCN¥117M
Free cash flow-CN¥257M-CN¥304M-CN¥75.8M-CN¥43.0M-CN¥108M
Capital expenditureCN¥249MCN¥287MCN¥210MCN¥113MCN¥162M
Total debtCN¥438MCN¥781MCN¥508MCN¥403MCN¥27.7M

Quarterly statements and history in the cockpit →

Shandong Linuo Pharmaceutical Packaging competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%-40%-20%0%601121000525002302600963301190301683002057002810300905002366600810688231603155002803300834688359605007300109301188.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Shandong Linuo Pharmaceutical Packaging is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×60×600963002057002810600810688231603155002803300109301188.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shandong Linuo Pharmaceutical Packaging is the large dot.

Shandong Linuo Pharmaceutical Packaging competitors and peer comparison

Head to head with its named competitors (301188.SZ vs 301093.SZ vs WST)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Shandong Linuo Pharmaceutical Packaging 301188.SZ$814M-42%+30%3%64.4×n/a
Jiangsu Hualan New Pharmaceutical Material 301093.SZ$1.35B-46%+6%5%68.3×47.9%
West Pharmaceutical Services WST$28.1B+32%+13%23%40.2×25.8%

How Shandong Linuo Pharmaceutical Packaging compares with its peers

Peer set: Sector in the same market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shandong Linuo Pharmaceutical Packaging against its 20 peers (data as of 18 Nov 2026)
Measure301188.SZPeer medianRank in peer set
1-month return-24.2%-14.8%6th lowest of 21
6-month return-41.5%-30.6%4th lowest of 20
Distance from 52-week high-72.8%-46.6%3rd lowest of 21
Revenue growth (TTM)+30.1%+11.1%3rd highest of 21
Operating margin2.9%5.8%9th lowest of 21
Forward P/E64.4×17.4×most expensive of 10
ROIC minus cost of capital-7.6 pp-4.2 pp3rd lowest of 21

Peer table

Peer set: Sector in the same market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shandong Linuo Pharmaceutical Packaging 301188.SZChina$814M-42%+30%3%64.4×n/an/a
Xinjiang Baodi Mining 601121.SSChina$816M-21%+23%23%n/an/an/a
Nanjing Redsun 000525.SZChina$811M-17%+12%-2%n/a9.7%-5.1%
China West Construction 002302.SZChina$810M-21%-24%-7%n/a11.7%-5.0%
Yueyang Forest & Paper 600963.SSChina$819M-27%-10%-5%16.0×n/an/a
Zhejiang Great Southeast 002263.SZChina$820M-25%+5%-1%n/a30.3%-4.0%
Jiujiang Shanshui Technology 301190.SZChina$820M+6%+54%19%n/an/an/a
Guangzhou Human New Material Science & Technology 301683.SZChina$824M-35%+20%38%n/a8.9%n/a
Sinosteel New Materials 002057.SZChina$803M-26%+13%9%11.6×11.3%+13.5%
Shandong Head 002810.SZChina$826M-35%+16%21%13.4×-2.1%+7.9%
Poly Plastic Masterbatch (SuZhou) 300905.SZChina$827M-65%+10%11%n/a31.1%+17.2%
Guangdong Sinoplast Adv Matl 301686.SZChina$802Mn/a+7%19%n/an/an/a
RongFa Nuclear Equipment 002366.SZChina$827M-34%-15%-18%n/an/an/a
Shenma Industry 600810.SSChina$801M-31%-9%0%27.3×9.4%+7.1%
Jiangsu Longda Superalloy 688231.SSChina$800M-49%+54%6%28.2×n/an/a
Xinyaqiang Silicon Chemistry 603155.SSChina$798M-15%+25%12%37.4×22.5%+3.9%
Xiamen Jihong 002803.SZChina$798M-38%+12%6%17.4×2.9%+8.8%
Rastar Environmental Protection Materials 300834.SZChina$832M-37%-23%1%n/a41.3%0.0%
Guangzhou Sanfu Newmaterials Technology 688359.SSChina$832M-54%+8%-7%n/an/an/a
Wuzhou Special Paper 605007.SSChina$832M-21%+17%5%11.6×n/an/a
Boai NKY Medical 300109.SZChina$796M-40%-17%15%28.9×17.6%+3.9%

Questions

Who are Shandong Linuo Pharmaceutical Packaging's main competitors?
Named competitors: Jiangsu Hualan New Pharmaceutical Material (301093.SZ), West Pharmaceutical Services (WST). The cockpit's measured peer set (sector in the same market, nearest in size) also includes Xinjiang Baodi Mining (601121.SS), Nanjing Redsun (000525.SZ), China West Construction (002302.SZ), Yueyang Forest & Paper (600963.SS), Zhejiang Great Southeast (002263.SZ), Jiujiang Shanshui Technology (301190.SZ).
Is Shandong Linuo Pharmaceutical Packaging expensive compared with its peers?
On forward p/e it trades at 64.4× against a peer median of 17.4×, most expensive of 10 in its peer set.
How has Shandong Linuo Pharmaceutical Packaging stock performed?
Over six months to 18 Nov 2026 the shares returned -41.5% against -30.6% for the median peer; over one year +21.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.